Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy

被引：0
|
作者：
Godfrey, James [1 ]
Querfeld, Christiane [1 ]
Song, Joo [1 ]
Hamilton, Mark P. [2 ]
Miklos, David B. [2 ]
Alizadeh, Ash A. [2 ]
机构：
[1] City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA
[2] Stanford Univ, Sch Med, Stanford, CA USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 391卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：869 / 871
页数：3
相关论文
共 50 条
  • [21] FDA Approves second CAR T-cell Therapy
    Calmes-Miller, Jordan
    CANCER DISCOVERY, 2018, 8 (01) : 5 - 6
  • [22] Treatment strategies for relapse after CAR T-cell therapy in B cell lymphoma
    Negishi, Shuto
    Girsch, James H.
    Siegler, Elizabeth L.
    Bezerra, Evandro D.
    Miyao, Kotaro
    Sakemura, R. Leo
    FRONTIERS IN PEDIATRICS, 2024, 11
  • [23] CAR T-Cell Therapy in Large B-Cell Lymphoma
    Quintas-Cardama, Alfonso
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (11): : 1065 - 1065
  • [24] CAR T-Cell Therapy and Bispecific Antibodies in Mantle Cell Lymphoma
    Kallam, Avyakta
    Danilov, Alexey
    Phillips, Tycel J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S124 - S125
  • [25] CAR T-Cells for T-cell Lymphoma
    Hill, LaQuisa C.
    Rouce, Rayne H.
    Mamonkin, Maksim
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S173 - S174
  • [26] T-cell lymphoma gene fusion augments T-cell therapy
    Green, Kathleen J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (07) : 1420 - 1420
  • [27] Case Report: Refractory Cryptosporidiosis after CAR T-Cell Therapy for Lymphoma
    Trottier, Caitlin A.
    Yen, Christina F.
    Malvar, Grace
    Arnason, Jon
    Avigan, David E.
    Alonso, Carolyn D.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (03): : 651 - 653
  • [28] Aggressive Lymphoma after CD19 CAR T-Cell Therapy
    Kobbe, Guido
    Bruggemann, Monika
    Baermann, Ben-Niklas
    Wiegand, Laura
    Trautmann, Heiko
    Yousefian, Schayan
    Libertini, Silvana
    Menssen, Hans D.
    Maier, Harald J.
    Ulrich, Peter
    Gao, Jingbo
    Bruch, Peter-Martin
    Liebers, Nora
    Radujkovic, Aleksandar
    Seifert, Marc
    Schniederjohann, Christina
    Paramasivam, Nagarajan
    Fitzgerald, Donnacha
    Seidel, Maximilian
    Esposito, Irene
    Germing, Ulrich
    Cadeddu, Ron-Patrick
    Nachtkamp, Kathrin
    Jaeger, Paul
    Ulrych, Thomas
    Fischer, Johannes C.
    Rox, Jutta M.
    Giesel, Frederik
    Koch, Raphael
    Antoch, Gerald
    Distler, Joerg H. W.
    Meuth, Sven G.
    Jacobsen, Malte
    Hubschmann, Daniel
    Lu, Junyan
    Iaccarino, Ingram
    Haas, Simon
    Damm, Frederik
    Dietrich, Sascha
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (13): : 1217 - 1226
  • [29] Longitudinal analysis of CAR T-cell and immune cell populations in patients with aggressive B-cell non-Hodgkin Lymphoma: T-cell phenotypes predict the outcomes after CAR T-cell therapy
    Chitadze, G.
    Stuebig, T.
    Laqua, A.
    Nakov, P.
    Kehden, B.
    Khouja, M.
    Versteegen, T.
    Schroeder, T.
    Martens, T.
    Lohneis, A.
    Iaccarino, I.
    Klapper, W.
    Peipp, M.
    Klausz, K.
    Ritgen, M.
    Adam, S.
    Schuster, S. O.
    Fransecky, L.
    Valerius, T.
    Schub, N.
    Stoelzel, F.
    Brueggemann, M.
    Baldus, C. D.
    Pott, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 74 - 74
  • [30] T-cell therapies for T-cell lymphoma
    Toner, Keri
    Bollard, Catherine M.
    Dave, Hema
    CYTOTHERAPY, 2019, 21 (09) : 935 - 942
12345